Recurrent Transformed Chronic Lymphocytic Leukemia
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06769 | Bendamustine | 1 | Recruiting | 2 |
| DB00531 | Cyclophosphamide | 1 | Not Yet Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 3 |
| DB01073 | Fludarabine | 1 | Not Yet Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 3 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 2 |
| DB01073 | Fludarabine | 2 | Recruiting | 2 |
| DB09053 | Ibrutinib | 2 | Recruiting | 1 |
| DB16582 | Lisocabtagene maraleucel | 2 | Recruiting | 2 |
| DB16222 | Loncastuximab tesirine | 2 | Recruiting | 1 |
| DB15434 | Mosunetuzumab | 2 | Recruiting | 1 |
| DB00075 | Muromonab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Withdrawn | 1 |
| DB08935 | Obinutuzumab | 2 | Recruiting | 1 |
| DB00073 | Rituximab | 2 | Withdrawn | 1 |
| DB11581 | Venetoclax | 2 | Recruiting | 1 |
| DB11581 | Venetoclax | 2 | Withdrawn | 1 |
| DB15035 | Zanubrutinib | 2 | Recruiting | 1 |